Pharmaceutical manufacturer.
Policy issues relating to Public Law No. 113-54, the "Drug Quality and Security Act."
Policy issues relating to Public Law No. 111-148, the "Patient Protection and Affordable Care Act."
Policy issues relating to Public Law No. 112-144, the "Food and Drug Administration Safety and Innovation Act," specifically those sections relating to the implementation of the Prescription Drug User Fee program and the Medical Device User Free program.
Policy issues relating to a proposed FDA regulation on generic drug labeling.
HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE
FERGUSON STRATEGIES, LLC
801 Pennsylvania Ave NW, Suite 230, Washington, DC, 20004-2697, US
CHRIS JONES ADAM HIGGINS